Neurizon Therapeutics LTD. (<a href= "https://www.otcmarkets.com/stock/NUZTF/quote" target="_blank" rel= "noopener">OTCQB: NUZTF</a>) is an Australian clinical-stage biotech company focused on developing treatments for neurodegenerative diseases, with their lead program aimed at ALS. Michael Thurn, CEO and Managing Director of Neurizon, joins us to discuss their mission to address neurodegenerative diseases through its lead ALS therapy <a href= "https://www.otcmarkets.com/files/OTCQBPodcast_Neurizon_Season10Episode4.pdf" target="_blank" rel="noopener"> View Podcast Transcript</a>

Neurizon Therapeutics LTD. (OTCQB: NUZTF) is an Australian clinical-stage biotech company focused on developing treatments for neurodegenerative diseases, with their lead program aimed at ALS. Michael Thurn, CEO and Managing Director of Neurizon, joins us to discuss their mission to address neurodegenerative diseases through its lead ALS therapy View Podcast Transcript

Neurizon Therapeutics LTD. (<a href="https://www.otcmarkets.com/stock/NUZTF/quote" rel="noopener noreferrer">OTCQB: NUZTF</a>) is an Australian clinical-stage biotech company focused on developing treatments for neurodegenerative diseases, with their lead program aimed at ALS. Michael Thurn, CEO and Managing Director of Neurizon, joins us to discuss their mission to address neurodegenerative diseases through its lead ALS therapy <a href="https://www.otcmarkets.com/files/OTCQBPodcast_Neurizon_Season10Episode4.pdf" rel="noopener noreferrer"> View Podcast Transcript</a>

Neurizon Therapeutics LTD.

OTC Markets presents our podcast series on the OTCQB Market, where we interview the entrepreneurs behind the companies that trade on the venture market.

Share Neurizon Therapeutics LTD.

Sign up to save your podcasts

Neurizon Therapeutics LTD.

Neurizon Therapeutics LTD.